Skip to content

Amylyx Pharmaceuticals, Inc.

AMLX Nasdaq SEC CIK 1658551

Follow Amylyx Pharmaceuticals Weekly email: filings, results, news

News

8 stories filed under Amylyx Pharmaceuticals, grouped into ongoing threads

Avexitide

Thread · 4 stories

Amylyx (AMLX) Faces a Binary Phase 3 Test. Can Avexitide Rebuild the Company?

Markets 34 d ago

Amylyx (AMLX) Climbs to Fresh High as Avexitide Moves Closer to Commercialization

Markets 37 d ago

Amylyx Pharmaceuticals, Inc. (AMLX) Discusses Positive Phase III LUCIDITY Topline Results for Avexitide in Post-Bariatric Hypoglycemia - Slideshow

Markets 37 d ago also on III

Amylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild

Markets 48 d ago

More coverage

Why is Amylyx Pharmaceuticals stock surging today?

Markets 37 d ago 2 sources

AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial

Markets 37 d ago also on GLP

Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2026 Earnings Call Transcript

Earnings 49 d ago

Amylyx Pharmaceuticals earnings up next as trial data looms

Earnings 49 d ago 2 sources

Next results

NOV5

FY 2026 results

Thursday · estimated from the filing cadence

Profile

Headquarters: CAMBRIDGE, MA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 8 stories clustered from the RSS aggregator